tirzepatide 13 units Medical Necessity Letter Template Tirzepatide for Medical Weight Management

Mounjaro must stay refrigerated (2C8C) until you take your first dose

Obesity and Overweight Fact Sheet

Graphical abstract Similar content being viewed by others Introduction Tirzepatide (LY3298176) is the first peptide dual agonist for type 2 diabetes mellitus (T2DM), which targets both GIPR and GLP1R

You dont need to worry about the technical detailsour medical team will assess your eligibility and clearly explain your options

The program is designed for adults 18 and older who meet standard GLP-1 prescribing eligibility criteria - typically BMI 30 or higher, or BMI 27 or higher with at least one qualifying weight-related condition (such as hypertension, type 2 diabetes, dyslipidemia, or sleep apnea)

Diabetes, Metabolic Syndrome and Obesity, 15, 10231030